157 related articles for article (PubMed ID: 35811933)
1. Impact of Composition and Morphology of Ketoconazole-Loaded Solid Lipid Nanoparticles on Intestinal Permeation and Gastroplus-Based Prediction Studies.
Aljurbui SJ; Hussain A; Yusuf M; Ramzan M; Afzal O; Almohaywi B; Yasmin S; Altamimi ASA
ACS Omega; 2022 Jul; 7(26):22406-22420. PubMed ID: 35811933
[TBL] [Abstract][Full Text] [Related]
2. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery.
Ramzan M; Gourion-Arsiquaud S; Hussain A; Gulati JS; Zhang Q; Trehan S; Puri V; Michniak-Kohn B; Kaur IP
Drug Deliv Transl Res; 2022 Jul; 12(7):1659-1683. PubMed ID: 34993923
[TBL] [Abstract][Full Text] [Related]
3. GastroPlus- and HSPiP-Oriented Predictive Parameters as the Basis of Valproic Acid-Loaded Mucoadhesive Cationic Nanoemulsion Gel for Improved Nose-to-Brain Delivery to Control Convulsion in Humans.
Hussain A; Altamimi MA; Ramzan M; Mirza MA; Khuroo T
Gels; 2023 Jul; 9(8):. PubMed ID: 37623058
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole-Loaded Cationic Nanoemulsion:
Shahid M; Hussain A; Khan AA; Ramzan M; Alaofi AL; Alanazi AM; Alanazi MM; Rauf MA
ACS Omega; 2022 Jun; 7(23):20267-20279. PubMed ID: 35721949
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
[TBL] [Abstract][Full Text] [Related]
8. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Dudhipala N; Ali Youssef AA; Banala N
Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
10. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
[TBL] [Abstract][Full Text] [Related]
11. Solidified SNEDDS for the oral delivery of rifampicin: Evaluation, proof of concept, in vivo kinetics, and in silico GastroPlus
Hussain A; Shakeel F; Singh SK; Alsarra IA; Faruk A; Alanazi FK; Peter Christoper GV
Int J Pharm; 2019 Jul; 566():203-217. PubMed ID: 31132448
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
13. Development and Optimization of Itraconazole-Loaded Solid Lipid Nanoparticles for Topical Administration Using High Shear Homogenization Process by Design of Experiments: In Vitro, Ex Vivo and In Vivo Evaluation.
Kumar N; Goindi S
AAPS PharmSciTech; 2021 Oct; 22(7):248. PubMed ID: 34647162
[TBL] [Abstract][Full Text] [Related]
14. Topical Amphotericin B solid lipid nanoparticles: Design and development.
Butani D; Yewale C; Misra A
Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
[TBL] [Abstract][Full Text] [Related]
15. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Gill P; Valizadeh H; Nokhodchi A
Colloids Surf B Biointerfaces; 2015 Apr; 128():473-479. PubMed ID: 25797482
[TBL] [Abstract][Full Text] [Related]
16. Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin.
Han SB; Kwon SS; Jeong YM; Yu ER; Park SN
Int J Cosmet Sci; 2014 Dec; 36(6):588-97. PubMed ID: 25220288
[TBL] [Abstract][Full Text] [Related]
17. Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: Optimization, characterization and cytotoxicity evaluation.
Kaur R; Sharma N; Tikoo K; Sinha VR
Int J Pharm; 2020 Aug; 586():119439. PubMed ID: 32622808
[TBL] [Abstract][Full Text] [Related]
18.
Sadozai SK; Khan SA; Baseer A; Ullah R; Zeb A; Schneider M
Front Pharmacol; 2022; 13():909851. PubMed ID: 35873577
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use.
Aggarwal N; Goindi S
J Biomed Nanotechnol; 2013 Apr; 9(4):564-76. PubMed ID: 23621015
[TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
